News
MedInvest is hosting a Biotech and Pharma Investor Conference March 31-April 1, 2026 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is
NIH has 1,200 scientists in the Intramural Research Program who research and develop new drugs, vaccines, methods, and other products to better public health. These scientists become inventors when their research results in a licensable material or product. The NIH Record chatted with two of them
The AUTM on the Air podcast has recently produced an episode featuring the NIH’s Dr. Mukul Ranjan discussing the origins of the Nagoya Protocol and its ongoing challenges, as well as the United States’ decision to not participate. The Nagoya Protocol is a supplement to the UN’s convention on
The Bayh-Dole Coalition has made all of the key documents in the Bayh-Dole legislation public and virtually accessible through a new online library. Previously, these documents were inaccessible and not housed together. Now, these documents have been compiled and annotated with the intent of